Status:

COMPLETED

Treatment of Comorbid Depression and Substance Abuse in Young People

Lead Sponsor:

Dan Lubman

Conditions:

Depression

Substance-Related Disorders

Eligibility:

All Genders

16-26 years

Phase:

PHASE2

Brief Summary

This study aims to treat young people with an adjunctive integrated cognitive behavioral therapy (CBT) intervention and to examine the acceptability of this treatment approach within this population. ...

Detailed Description

The high prevalence of co-occurring depressive and substance use disorders amongst young people is especially problematic given the significant negative impact on both symptom course and outcome repor...

Eligibility Criteria

Inclusion

  • 16 and 26 years of age
  • acute major depressive episode (more than one month)
  • concurrent DSM-IV substance abuse/dependence or the use of any illicit drug on a weekly basis in the month prior to referral, or alcohol consumption exceeding NHMRC guidelines
  • English as their preferred language
  • estimated IQ \>80

Exclusion

  • Current or past history of psychosis
  • significant head injury
  • seizures
  • history or current evidence of any other significant clinical condition
  • treatment with an antidepressant within past 30 days

Key Trial Info

Start Date :

September 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2009

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00232284

Start Date

September 1 2004

End Date

May 1 2009

Last Update

June 26 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

ORYGEN Youth Health

Melbourne, Victoria, Australia, 3052

Treatment of Comorbid Depression and Substance Abuse in Young People | DecenTrialz